One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
JAMA Dermatology.
doi : 10.1001/jamadermatol.2023.4012
Volume 160(12) pgs. 1267-1371 December 2024
Relative, Absolute, and Excess Risk of Second Primary Melanomas Among Multiple Racial and Ethnic Groups-Analysis of Rare Events.
Long-Term Risk of Autoimmune and Autoinflammatory Connective Tissue Disorders Following COVID-19.
Incidence, In-Hospital and Long-Term Mortality, and Sequelae of Epidermal Necrolysis in Adults.
Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis: Analysis of 3 Phase 3 Randomized Clinical Trials Through 76 Weeks.
Pregabalin for Neuropathic Pain and Itch in Recessive Dystrophic Epidermolysis Bullosa: A Randomized Crossover Trial.
Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis: The LITE Randomized Clinical Trial.
Lipodermatosclerosis and Pulmonary Hypertension in Systemic Sclerosis.
Low-Dose Naltrexone Use in Biopsy-Proven Lichen Planus of the Nails.
Impact of Clinical Information on Melanocytic Skin Lesion Pathology Diagnosis: A Scoping Review.
Validation of the Delphi Consensus Diagnostic Criteria for Necrobiotic Xanthogranuloma.
Racial and Ethnic Differences in the Risk of Second Primary Melanoma.
Prevalence and Patient Characteristics of Pachyonychia Congenita.
Tralokinumab and Acitretin for the Treatment of Lamellar Ichthyosis.
Successful Treatment of Recalcitrant Chloracne With Adalimumab in an Older Man.
